Follow The Filings

ANAB AnaptysBio

AnaptysBio earnings company data as of 7:04 PM ET 11/19

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2027 Q1 12 Nov EPS 0.41 GAAP 0.11 —
Rev — $1.00B —
FY2026 Q4 23 Sep EPS 0.14 — —
Rev — — —

Insider trades

Open-market buys and sales by ANAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ANAB insider trades
  • $17.2M bought by 1 insider
  • $1.9M sold by 3 insiders outside a trading plan
  • $4M sold by 4 insiders under 10b5-1 plans
  1. EcoR1 Capital, LLC Director, +1 joint filer
    Buy
    $17.2M 374,580 shares at $45.98 +4.8% to stake
    Traded Nov 16–18 Filed Nov 18
  2. Hollings Renton Director
    Planned sale
    $249K 5,000 shares at $49.87 31% of stake
    Traded Oct 1 Filed Oct 2
  3. John P. Schmid Director
    Sale
    $1.2M 20,645 shares at $56.11 40% of stake
    Traded Mar 30 Filed Apr 1
  4. Eric J. Loumeau Chief Legal Officer
    Planned sale
    $540K 10,000 shares at $54.00 44% of stake
    Traded Feb 11 Filed Feb 13
  5. Magda Marquet Director
    Sale
    $531K 11,000 shares at $48.23 53% of stake
    Traded Jan 15 Filed Jan 16
  6. Eric J. Loumeau Chief Legal Officer
    Planned sale
    $348K 7,622 shares at $45.69 45% of stake
    Traded Jan 7 Filed Jan 8
  7. J. Anthony Ware Director
    Sale
    $193K 3,900 shares at $49.58 29% of stake
    Traded Dec 23, 2025 Filed Dec 23, 2025
  8. Paul F. Lizzul Chief Medical Officer
    Planned sale
    $75K 1,500 shares at $50.00 5.3% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
  9. Dennis Mulroy CFO
    Planned sale
    $500K 10,000 shares at $50.00 52% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
  10. Eric J. Loumeau Chief Legal Officer
    Planned sale
    $510K 10,000 shares at $51.00 53% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
  11. Dennis Mulroy CFO
    Planned sale
    $705K 15,725 shares at $44.85 63% of stake
    Traded Dec 16, 2025 Filed Dec 18, 2025
  12. Eric J. Loumeau Chief Legal Officer
    Planned sale
    $1M 22,641 shares at $45.38 72% of stake
    Traded Dec 16–18 Filed Dec 18, 2025

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises, 22 sales to cover taxes, 1 stock grant, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
SCHEDULE 13D/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 9.01
SCHEDULE 13G/A —
8-K 5.07,9.01
8-K 7.01
DEF 14A
DEFA14A
8-K 1.01
8-K 7.01
8-K 5.03
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02
10-K/A
8-K/A 9.01
8-K 1.01,2.01,5.02,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf